drugset / Trial / NCT04063930
The Effect of Sodium Zirconium Cyclosilicate on Albuminuria in Patients With Type 2 Diabetes and Hyperkalemia
Phase 4
Unknown
20 enrolled
Steno Diabetes Center Copenhagen
AstraZeneca · collabZealand University Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To investigate whether concomitant treatment with Lokelma can improve the efficacy of standard blockade of the renin-angiotensin system in patients with type 2 diabetes, diabetic nephropathy and hyperkalemia.
Timeline
- Start
- 2019-10
- Primary completion
- 2020-12
- Completion
- 2021-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sodium Zirconium Cyclosilicate | Other / unclassified | 5 g | Oral |